Global Therapeutic Nuclear Medicines Market Research Report 2020

Global Therapeutic Nuclear Medicines Market Research Report 2020

Table of Contents
1 Therapeutic Nuclear Medicines Market Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Therapeutic Nuclear Medicines Segment by Type
1.2.1 Global Therapeutic Nuclear Medicines Production Growth Rate Comparison by Type 2020 VS 2026
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Therapeutic Nuclear Medicines Segment by Application
1.3.1 Therapeutic Nuclear Medicines Consumption Comparison by Application: 2020 VS 2026
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Global Therapeutic Nuclear Medicines Market by Region
1.4.1 Global Therapeutic Nuclear Medicines Market Size Estimates and Forecasts by Region: 2020 VS 2026
1.4.2 North America Estimates and Forecasts (2015-2026)
1.4.3 Europe Estimates and Forecasts (2015-2026)
1.4.4 China Estimates and Forecasts (2015-2026)
1.4.5 Japan Estimates and Forecasts (2015-2026)
1.5 Global Therapeutic Nuclear Medicines Growth Prospects
1.5.1 Global Therapeutic Nuclear Medicines Revenue Estimates and Forecasts (2015-2026)
1.5.2 Global Therapeutic Nuclear Medicines Production Capacity Estimates and Forecasts (2015-2026)
1.5.3 Global Therapeutic Nuclear Medicines Production Estimates and Forecasts (2015-2026)
2 Market Competition by Manufacturers
2.1 Global Therapeutic Nuclear Medicines Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2015-2020)
2.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.4 Global Therapeutic Nuclear Medicines Average Price by Manufacturers (2015-2020)
2.5 Manufacturers Therapeutic Nuclear Medicines Production Sites, Area Served, Product Types
2.6 Therapeutic Nuclear Medicines Market Competitive Situation and Trends
2.6.1 Therapeutic Nuclear Medicines Market Concentration Rate
2.6.2 Global Top 3 and Top 5 Players Market Share by Revenue
2.6.3 Mergers & Acquisitions, Expansion
3 Production Capacity by Region
3.1 Global Production Capacity of Therapeutic Nuclear Medicines Market Share by Regions (2015-2020)
3.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Regions (2015-2020)
3.3 Global Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 North America Therapeutic Nuclear Medicines Production
3.4.1 North America Therapeutic Nuclear Medicines Production Growth Rate (2015-2020)
3.4.2 North America Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Therapeutic Nuclear Medicines Production
3.5.1 Europe Therapeutic Nuclear Medicines Production Growth Rate (2015-2020)
3.5.2 Europe Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 China Therapeutic Nuclear Medicines Production
3.6.1 China Therapeutic Nuclear Medicines Production Growth Rate (2015-2020)
3.6.2 China Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Japan Therapeutic Nuclear Medicines Production
3.7.1 Japan Therapeutic Nuclear Medicines Production Growth Rate (2015-2020)
3.7.2 Japan Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
4 Global Therapeutic Nuclear Medicines Consumption by Regions
4.1 Global Therapeutic Nuclear Medicines Consumption by Regions
4.1.1 Global Therapeutic Nuclear Medicines Consumption by Region
4.1.2 Global Therapeutic Nuclear Medicines Consumption Market Share by Region
4.2 North America
4.2.1 North America Therapeutic Nuclear Medicines Consumption by Countries
4.2.2 U.S.
4.2.3 Canada
4.3 Europe
4.3.1 Europe Therapeutic Nuclear Medicines Consumption by Countries
4.3.2 Germany
4.3.3 France
4.3.4 U.K.
4.3.5 Italy
4.3.6 Russia
4.4 Asia Pacific
4.4.1 Asia Pacific Therapeutic Nuclear Medicines Consumption by Region
4.4.2 China
4.4.3 Japan
4.4.4 South Korea
4.4.5 Taiwan
4.4.6 Southeast Asia
4.4.7 India
4.4.8 Australia
4.5 Latin America
4.5.1 Latin America Therapeutic Nuclear Medicines Consumption by Countries
4.5.2 Mexico
4.5.3 Brazil
5 Production, Revenue, Price Trend by Type
5.1 Global Therapeutic Nuclear Medicines Production Market Share by Type (2015-2020)
5.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2015-2020)
5.3 Global Therapeutic Nuclear Medicines Price by Type (2015-2020)
5.4 Global Therapeutic Nuclear Medicines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
6 Global Therapeutic Nuclear Medicines Market Analysis by Application
6.1 Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020)
6.2 Global Therapeutic Nuclear Medicines Consumption Growth Rate by Application (2015-2020)
7 Company Profiles and Key Figures in Therapeutic Nuclear Medicines Business
7.1 Bayer
7.1.1 Bayer Therapeutic Nuclear Medicines Production Sites and Area Served
7.1.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification
7.1.3 Bayer Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.1.4 Main Business and Markets Served
7.2 Novartis AG
7.2.1 Novartis AG Therapeutic Nuclear Medicines Production Sites and Area Served
7.2.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification
7.2.3 Novartis AG Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.2.4 Main Business and Markets Served
7.3 China Isotope & Radiation
7.3.1 China Isotope & Radiation Therapeutic Nuclear Medicines Production Sites and Area Served
7.3.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification
7.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.3.4 Main Business and Markets Served
7.4 Dongcheng
7.4.1 Dongcheng Therapeutic Nuclear Medicines Production Sites and Area Served
7.4.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification
7.4.3 Dongcheng Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Main Business and Markets Served
7.5 Q BioMed
7.5.1 Q BioMed Therapeutic Nuclear Medicines Production Sites and Area Served
7.5.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification
7.5.3 Q BioMed Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.5.4 Main Business and Markets Served
7.6 Curium Pharmaceuticals
7.6.1 Curium Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served
7.6.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification
7.6.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.6.4 Main Business and Markets Served
7.7 Jubilant DraxImage
7.7.1 Jubilant DraxImage Therapeutic Nuclear Medicines Production Sites and Area Served
7.7.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification
7.7.3 Jubilant DraxImage Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.4.4 Main Business and Markets Served
7.8 Lantheus
7.8.1 Lantheus Therapeutic Nuclear Medicines Production Sites and Area Served
7.8.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification
7.8.3 Lantheus Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.8.4 Main Business and Markets Served
7.9 Spectrum Pharmaceuticals
7.9.1 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served
7.9.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification
7.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.9.4 Main Business and Markets Served
7.10 Progenics Pharmaceuticals
7.10.1 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served
7.10.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification
7.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.10.4 Main Business and Markets Served
7.11 International Isotopes
7.11.1 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served
7.11.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification
7.11.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
7.11.4 Main Business and Markets Served
.1 International Isotopes Therapeutic Nuclear Medicines Production Sites and Area Served
.2 Therapeutic Nuclear Medicines Product Introduction, Application and Specification
.3 International Isotopes Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020)
.4 Main Business and Markets Served
8 Therapeutic Nuclear Medicines Manufacturing Cost Analysis
8.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Raw Materials Price Trend
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines
8.4 Therapeutic Nuclear Medicines Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Therapeutic Nuclear Medicines Distributors List
9.3 Therapeutic Nuclear Medicines Customers
10 Market Dynamics
10.1 Market Trends
10.2 Opportunities and Drivers
10.3 Challenges
10.4 Porter's Five Forces Analysis
11 Production and Supply Forecast
11.1 Global Forecasted Production of Therapeutic Nuclear Medicines (2021-2026)
11.2 Global Forecasted Revenue of Therapeutic Nuclear Medicines (2021-2026)
11.3 Global Forecasted Price of Therapeutic Nuclear Medicines (2021-2026)
11.4 Global Therapeutic Nuclear Medicines Production Forecast by Regions (2021-2026)
11.4.1 North America Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026)
11.4.2 Europe Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026)
11.4.3 China Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026)
11.4.4 Japan Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026)
12 Consumption and Demand Fprecast
12.1 Global Forecasted and Consumption Demand Analysis of Therapeutic Nuclear Medicines
12.2 North America Forecasted Consumption of Therapeutic Nuclear Medicines by Country
12.3 Europe Market Forecasted Consumption of Therapeutic Nuclear Medicines by Country
12.4 Asia Pacific Market Forecasted Consumption of Therapeutic Nuclear Medicines by Regions
12.5 Latin America Forecasted Consumption of Therapeutic Nuclear Medicines
13 Forecast by Type and by Application (2021-2026)
13.1 Global Production, Revenue and Price Forecast by Type (2021-2026)
13.1.1 Global Forecasted Production of Therapeutic Nuclear Medicines by Type (2021-2026)
13.1.2 Global Forecasted Revenue of Therapeutic Nuclear Medicines by Type (2021-2026)
13.1.2 Global Forecasted Price of Therapeutic Nuclear Medicines by Type (2021-2026)
13.2 Global Forecasted Consumption of Therapeutic Nuclear Medicines by Application (2021-2026)
14 Reseach Finding and Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Tables
Table 1. Global Therapeutic Nuclear Medicines Production (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Therapeutic Nuclear Medicines Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 3. Global Therapeutic Nuclear Medicines Consumption (K Units) Comparison by Application: 2020 VS 2026
Table 4. Global Therapeutic Nuclear Medicines Production (K Units) by Manufacturers
Table 5. Global Therapeutic Nuclear Medicines Production (K Units) by Manufacturers (2015-2020)
Table 6. Global Therapeutic Nuclear Medicines Production Share by Manufacturers (2015-2020)
Table 7. Global Therapeutic Nuclear Medicines Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2015-2020)
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Nuclear Medicines as of 2019)
Table 10. Global Market Therapeutic Nuclear Medicines Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 11. Manufacturers Therapeutic Nuclear Medicines Production Sites and Area Served
Table 12. Manufacturers Therapeutic Nuclear Medicines Product Types
Table 13. Global Therapeutic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14.Mergers & Acquisitions, Expansion
Table 15. Global Therapeutic Nuclear Medicines Capacity (K Units) by Region (2015-2020)
Table 16. Global Therapeutic Nuclear Medicines Production (K Units) by Region (2015-2020)
Table 17. Global Therapeutic Nuclear Medicines Revenue (Million US$) by Region (2015-2020)
Table 18. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2015-2020)
Table 19. Global Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 20. North America Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 21. Europe Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 22. China Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 23. Japan Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 24. Global Therapeutic Nuclear Medicines Consumption (K Units) Market by Region (2015-2020)
Table 25. Global Therapeutic Nuclear Medicines Consumption Market Share by Region (2015-2020)
Table 26. North America Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)
Table 27. Europe Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)
Table 28. Asia Pacific Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)
Table 29. Latin America Therapeutic Nuclear Medicines Consumption by Countries (2015-2020) (K Units)
Table 30. Global Therapeutic Nuclear Medicines Production (K Units) by Type (2015-2020)
Table 31. Global Therapeutic Nuclear Medicines Production Share by Type (2015-2020)
Table 32. Global Therapeutic Nuclear Medicines Revenue (Million US$) by Type (2015-2020)
Table 33. Global Therapeutic Nuclear Medicines Revenue Share by Type (2015-2020)
Table 34. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Type (2015-2020)
Table 35. Global Therapeutic Nuclear Medicines Consumption (K Units) by Application (2015-2020)
Table 36. Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020)
Table 37. Global Therapeutic Nuclear Medicines Consumption Growth Rate by Application (2015-2020)
Table 38. Bayer Therapeutic Nuclear Medicines Production Sites and Area Served
Table 39. Bayer Production Sites and Area Served
Table 40. Bayer Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 41. Bayer Main Business and Markets Served
Table 42. Novartis AG Therapeutic Nuclear Medicines Production Sites and Area Served
Table 43. Novartis AG Production Sites and Area Served
Table 44. Novartis AG Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 45. Novartis AG Main Business and Markets Served
Table 46. China Isotope & Radiation Therapeutic Nuclear Medicines Production Sites and Area Served
Table 47. China Isotope & Radiation Production Sites and Area Served
Table 48. China Isotope & Radiation Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 49. China Isotope & Radiation Main Business and Markets Served
Table 50. Dongcheng Therapeutic Nuclear Medicines Production Sites and Area Served
Table 51. Dongcheng Production Sites and Area Served
Table 52. Dongcheng Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 53. Dongcheng Main Business and Markets Served
Table 54. Q BioMed Therapeutic Nuclear Medicines Production Sites and Area Served
Table 55. Q BioMed Production Sites and Area Served
Table 56. Q BioMed Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 57. Q BioMed Main Business and Markets Served
Table 58. Curium Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served
Table 59. Curium Pharmaceuticals Production Sites and Area Served
Table 60. Curium Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Curium Pharmaceuticals Main Business and Markets Served
Table 62. Jubilant DraxImage Therapeutic Nuclear Medicines Production Sites and Area Served
Table 63. Jubilant DraxImage Production Sites and Area Served
Table 64. Jubilant DraxImage Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 65. Jubilant DraxImage Main Business and Markets Served
Table 66. Lantheus Therapeutic Nuclear Medicines Production Sites and Area Served
Table 67. Lantheus Production Sites and Area Served
Table 68. Lantheus Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 69. Lantheus Main Business and Markets Served
Table 70. Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served
Table 71. Spectrum Pharmaceuticals Production Sites and Area Served
Table 72. Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Spectrum Pharmaceuticals Main Business and Markets Served
Table 74. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Sites and Area Served
Table 75. Progenics Pharmaceuticals Production Sites and Area Served
Table 76. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Progenics Pharmaceuticals Main Business and Markets Served
Table 78. International Isotopes Therapeutic Nuclear Medicines Production Sites and Area Served
Table 79. International Isotopes Production Sites and Area Served
Table 80. International Isotopes Therapeutic Nuclear Medicines Production Capacity (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. International Isotopes Main Business and Markets Served
Table 82. Production Base and Market Concentration Rate of Raw Material
Table 83. Key Suppliers of Raw Materials
Table 84. Therapeutic Nuclear Medicines Distributors List
Table 85. Therapeutic Nuclear Medicines Customers List
Table 86. Market Key Trends
Table 87. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 88. Key Challenges
Table 89. Global Therapeutic Nuclear Medicines Production (K Units) Forecast by Region (2021-2026)
Table 90. North America Therapeutic Nuclear Medicines Consumption Forecast 2021-2026 (K Units) by Country
Table 91. Europe Therapeutic Nuclear Medicines Consumption Forecast 2021-2026 (K Units) by Country
Table 92. Asia Pacific Therapeutic Nuclear Medicines Consumption Forecast 2021-2026 (K Units) by Regions
Table 93. Latin America Therapeutic Nuclear Medicines Consumption Forecast 2021-2026 (K Units) by Country
Table 94. Global Therapeutic Nuclear Medicines Consumption (K Units) Forecast by Regions (2021-2026)
Table 95. Global Therapeutic Nuclear Medicines Production (K Units) Forecast by Type (2021-2026)
Table 96. Global Therapeutic Nuclear Medicines Revenue (Million US$) Forecast by Type (2021-2026)
Table 97. Global Therapeutic Nuclear Medicines Price (USD/Unit) Forecast by Type (2021-2026)
Table 98. Global Therapeutic Nuclear Medicines Consumption (K Units) Forecast by Application (2021-2026)
Table 99.Research Programs/Design for This Report
Table 100.Key Data Information from Secondary Sources
Table 101.Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Therapeutic Nuclear Medicines
Figure 2. Global Therapeutic Nuclear Medicines Production Market Share by Type: 2020 VS 2026
Figure 3. Radium-223 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Iodine-131 Product Picture
Figure 6. Other Product Picture
Figure 7. Global Therapeutic Nuclear Medicines Consumption Market Share by Application: 2020 VS 2026
Figure 8. Thyroid
Figure 9. Bone Metastasis
Figure 10. Lymphoma
Figure 11. Other
Figure 12. North America Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate (2015-2026)
Figure 13. Europe Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate (2015-2026)
Figure 14. China Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate (2015-2026)
Figure 15. Japan Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate (2015-2026)
Figure 16. Global Therapeutic Nuclear Medicines Revenue (Million US$) (2015-2026)
Figure 17. Global Therapeutic Nuclear Medicines Production Capacity (K Units) (2015-2026)
Figure 18. Therapeutic Nuclear Medicines Production Share by Manufacturers in 2019
Figure 19. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers in 2019
Figure 20. Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Market Therapeutic Nuclear Medicines Average Price (USD/Unit) of Key Manufacturers in 2019
Figure 22. The Global 5 and 10 Largest Players: Market Share by Therapeutic Nuclear Medicines Revenue in 2019
Figure 23. Global Therapeutic Nuclear Medicines Production Market Share by Region (2015-2020)
Figure 24. Global Therapeutic Nuclear Medicines Production Market Share by Region in 2019
Figure 25. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2015-2020)
Figure 26. Global Therapeutic Nuclear Medicines Revenue Market Share by Region in 2019
Figure 27. Global Therapeutic Nuclear Medicines Production (K Units) Growth Rate (2015-2020)
Figure 28. North America Therapeutic Nuclear Medicines Production (K Units) Growth Rate (2015-2020)
Figure 29. Europe Therapeutic Nuclear Medicines Production (K Units) Growth Rate (2015-2020)
Figure 30. China Therapeutic Nuclear Medicines Production (K Units) Growth Rate (2015-2020)
Figure 31. Japan Therapeutic Nuclear Medicines Production (K Units) Growth Rate (2015-2020)
Figure 32. Global Therapeutic Nuclear Medicines Consumption Market Share by Region (2015-2020)
Figure 33. Global Therapeutic Nuclear Medicines Consumption Market Share by Region in 2019
Figure 34. North America Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 35. North America Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019
Figure 36. Canada Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 38. Europe Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 39. Europe Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019
Figure 40. Germany America Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 41. France Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 42. U.K. Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 43. Italy Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 44. Russia Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 45. Asia Pacific Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 46. Asia Pacific Therapeutic Nuclear Medicines Consumption Market Share by Regions in 2019
Figure 47. China Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 48. Japan Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 49. South Korea Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 50. Taiwan Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 51. Southeast Asia Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 52. India Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 53. Australia Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 54. Latin America Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 55. Latin America Therapeutic Nuclear Medicines Consumption Market Share by Countries in 2019
Figure 56. Mexico Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 57. Brazil Therapeutic Nuclear Medicines Consumption Growth Rate (2015-2020) (K Units)
Figure 58. Production Market Share of Therapeutic Nuclear Medicines by Type (2015-2020)
Figure 59. Production Market Share of Therapeutic Nuclear Medicines by Type in 2019
Figure 60. Revenue Share of Therapeutic Nuclear Medicines by Type (2015-2020)
Figure 61. Revenue Market Share of Therapeutic Nuclear Medicines by Type in 2019
Figure 62. Global Therapeutic Nuclear Medicines Production Growth by Type (2015-2020) (K Units)
Figure 63. Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2015-2020)
Figure 64. Global Therapeutic Nuclear Medicines Consumption Market Share by Application in 2019
Figure 65. Global Therapeutic Nuclear Medicines Consumption Growth Rate by Application (2015-2020)
Figure 66. Price Trend of Key Raw Materials
Figure 67. Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Figure 68. Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure 69. Therapeutic Nuclear Medicines Industrial Chain Analysis
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 72. Porter's Five Forces Analysis
Figure 73. Global Therapeutic Nuclear Medicines Production Capacity (K Units) and Growth Rate Forecast (2021-2026)
Figure 74. Global Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 75. Global Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 76. Global Therapeutic Nuclear Medicines Price and Trend Forecast (2021-2026)
Figure 77. Global Therapeutic Nuclear Medicines Production Market Share Forecast by Region (2021-2026)
Figure 78. North America Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 79. North America Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 80. Europe Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 81. Europe Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 82. China Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 83. China Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 84. Japan Therapeutic Nuclear Medicines Production (K Units) and Growth Rate Forecast (2021-2026)
Figure 85. Japan Therapeutic Nuclear Medicines Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 86. Global Forecasted and Consumption Demand Analysis of Therapeutic Nuclear Medicines
Figure 87. North America Therapeutic Nuclear Medicines Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 88. Europe Therapeutic Nuclear Medicines Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 89. Asia Pacific Therapeutic Nuclear Medicines Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 90. Latin America Therapeutic Nuclear Medicines Consumption (K Units) Growth Rate Forecast (2021-2026)
Figure 91. Global Therapeutic Nuclear Medicines Production (K Units) Forecast by Type (2021-2026)
Figure 92. Global Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type (2021-2026)
Figure 93. Global Therapeutic Nuclear Medicines Consumption Forecast by Application (2021-2026)
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs